Critical care in cirrhosis patients;Place de la réanimation chez le cirrhotique

Reanimation

Volumn 12, Issue 6, 2003, Pages 414-421

  Durand, F ^a   Francoz, C ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Albumins; Cirrhosis; Intensive care; Liver failure; Renal dialysis

Indexed keywords

ALBUMIN;

ACUTE KIDNEY FAILURE; BACTERIAL INFECTION; BLOOD CLOTTING; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; IMMUNE SYSTEM; INTENSIVE CARE; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; MULTIPLE ORGAN FAILURE; PORTAL HYPERTENSION; PROGNOSIS; RESPIRATORY SYSTEM; REVIEW;

EID: 0141625180     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1624-0693(03)00113-0     Document Type: Short Survey

References (38)

1. Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vaso-active systems and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastro-enterology 1988;94:482-7.
2. Maroto A, Gines P, Arroyo V, Gines A, Salo J, Claria J, et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatology 1993;17:788-93.
3. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994;20:1359-63.
4. Arroyo V, Bosch J, Mauri M, Viver J, Mas A, Rivera F, et al. Renin, aldosterone and renal hemodynamics in cirrhotics with ascites. Eur J Clin Invest 1979;9:63-73.
5. Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM, Cobos MA, Rodriguez-Eire JL, et al. Systemic and regional hemodynamics in patients with cirrhosis and ascites with and without functional renal failure. Gastro-enterology 1989;97:1304-12.
6. Rivolta R, Maggi A, Cazzaniga M, Castagnone D, Panzeri A, Solenghi D, et al. Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites. Hepatology 1998;28:1235-40.
7. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994;105:1528-37.
8. Colle IO, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003;37:401-9.
9. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993;18:353-8.
10. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticulo-endothelial system phagocytic activity in cirrhosis and its relations to bacterial infections and prognosis. Hepatology 1984;4:53-8.
11. Durand F. Réanimation des malades cirrhotiques: Quelles sont les limites? Press Med 1999;28:285-6.
12. Moreau R, Valla D. Indications et place de l'albumine, à l'exclusion du remplissage vasculaire, dans la prise en charge préopératoire ou postopératoire de l'hypertension portale. Ann Fr Anest Réanim 1996; 15:514-24.
13. Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastro-enterology 1996;111:1002-10.
14. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz del Arbol L, et al. Effect of intravenous albumin on renal impairement and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9.
15. Shortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-6.
16. Bernard B, Grangé JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastro-intestinal bleeding: a meta-analysis. Hepatology 1999;29:1655-61.
17. Walker S, Kreischgauer HP, Bode JC. Terlipressin vs somatostatin in bleeding oesophageal varices: a controlled double blind study. Hepatology 1992;15:1023-30.
18. Lebrec D, Poynard T, Bernuau J, Bercoff E, Nouel O, Capron JP, et al. A randomized controlled study of propranolol for prevention of prevention of recurrent gastro-intestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984;4:355-8.
19. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999;340:988-93.
20. Rössle M, Deibert P, Haag K, Ochs A, Olchewski M, Siegerstetter V, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt vs endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;349:1043-9.
21. Ramond MJ, Valla D, Mosnier JF, Degott C, Bernuau J, Rueff B, et al. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology 1989;10:488-93.
22. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, et al. Emergency banding ligation vs sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 1997;25:1101-4.
23. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyano-acrylate injection vs band ligation in the management of bleeding gastric varices. Hepatology 2001;33:1060-4.
24. Sanyal AJ, Freeman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, et al. Transjugular intrahepatic portosystemic shunt for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastro-enterology 1996;111:136-8.
25. Goulenok C, Bernard B, Cadranel JF, Thabut D, Di Martino V, Opolon P, et al. Flumazenil vs placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Aliment Pharmacol Ther 2002;16:361-72.
26. Moreau R, Durand F, Poynard T, Duhamel C, Cervoni JP, Ichaï P, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002; 122:923-30.
27. Ortega R, Ginès P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective non randomized study. Hepatology 2002;36:941-8.
28. Ganne-Carrié N, Hadengue A, Mathurin P, Durand F, Erlinger S, Benhamou JP. Hepatorenal Syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation. Dig Dis Sci 1996;41:1054-6.
29. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goelh H, et al. Molecular absorbent recycling system (MARS): clinical results of new membrane based-blood purification system for bio-artificial liver support. Artif Organs 1999;23:319-30.
30. Mitzner SR, Klammt S, Peszynski P, Hickstein H, Korten G, Stange J, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular absorbent recirculating system. Ther Apher 2001;5:417-22.
31. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective controlled study. Hepatology 2002;36:949-58.
32. Samuel D, Ichai P, Feray C, Saliba F, Azoulay D, Arulnaden JL, et al. Neurological improvement during bio-artificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation 2002;73:257-64.
33. Sussman NL, Chong MG, Koussayer T, He De, Shang TA, Whisennand HH, et al. Reversal of fulminant hepatic failure using an extra-corporeal liver assist device. Hepatology 1992;16:60-5.
34. Moreau R, Hadengue A, Soupison T, Kirstetter P, Mamzer MF, Vanjak D, et al. Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med 1992;20:746-50.
35. Kress JP, Rubin A, Pohlmann AS, Hall JB. Outcome of critically-ill patients denied consideration for liver transplantation. Am J Respir Crit Care Med 2000;162:418-23.
36. Zauner C, Schneeweiss B, Schneider B, Madl C, Klos H, Kranz A, et al. Short-term prognosis in critically-ill patients with liver cirrhosis: an evaluation of a new scoring system. Eur J Gastro-enterol Hepatol 2000;12:517-22.
37. Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffmann-Hog L, Arroliga AC. Predictors of mortality a resource utilization in cirrhotic patients admitted to the medical ICU. Chest 2001;119:1489-97.
38. Wehler M, Kokoska J, Reulbach U, Hahn EG, Strauss R. Short-term prognosis in critically-ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 2001;34:255-61.